Nordiet diet tested as a natural way to ease IBD symptoms

NCT ID NCT07389161

First seen Feb 05, 2026 · Last updated Jun 22, 2026 · Updated 19 times

Summary

This study is testing whether a Mediterranean-like diet called Nordiet can improve gut health and reduce inflammation in 160 teens and adults with Crohn's disease or ulcerative colitis. Participants will follow the diet for four weeks while researchers check changes in gut bacteria, disease activity, and quality of life. The goal is to see if diet alone can help manage IBD without changing other treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Skåne University Hospital

    RECRUITING

    Malmö, 21428, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Mediterranean-like diet (Nordiet)

What this could lead to

If it works, this could point toward a simple dietary approach to help manage IBD symptoms and reduce inflammation.

What could go wrong

This is a small, early-phase study with no control group, so results may not be conclusive. Diet changes alone may not be enough for moderate-to-severe disease.

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.